Abstract:Objective To investigate the regulatory effect of nobiletin (NOB) at typical effective doses on intestinal stem cells in vivo and in vitro. Methods After a 3D culture model of mouse colorectal tumor cell line MC38 was constructed, the death and survival of the obtained colonies were observed after treatment of different concentrations of NOB. Mouse small intestinal crypts were cultured in the Matrigel to generate organoids. Different concentrations of NOB were added to the culture system, and the sprouting and growth of the organoids were observed. MTT assay was used to calculate the area and absorbance values of the organoids after staining. The organoid growth was observed by removing 50 and 100 μmol/L NOB for different periods. The effects of exogenous R-spondin1 and CHIR99021 (activators of Wnt pathway) on the growth of organoids were observed in the culture system with 50 and 100 μmol/L NOB treatment. C57/B6J mice were infused with different concentrations of NOB by gavage for 4 consecutive days. The ratio of intestinal crypt to villus length, cell apoptosis, and number of OLfm4 and BrdU double positive cells were calculated and observed. Results Compared with the control group, 50 μmol/L NOB significantly promoted the death of MC38 cells after sphere formation and significantly reduced the colony formation rate (P < 0.001). The dose also significantly inhibited the budding of intestinal organoids, and 50~200 μmol/L NOB significantly inhibited the growth of intestinal organoids in a dose-dependent manner when compared with the control group (P < 0.001). After NOB withdrawal, the growth of intestinal organoids in the 50 μmol/L group was partially recovered, but it was difficult to recover to normal level in the 100 μmol/L NOB group. Enhanced Wnt pathway activation could partially rescue the inhibitory effect of NOB on intestinal organoids. In vivo administration of higher concentrations of NOB did not induce apoptosis of intestinal crypt cells, did not affect the crypt to villus ratio, and had no effects on the number and proliferation status of intestinal stem cells. Conclusion NOB possesses the ability to inhibit normal intestinal stem cells by regulating stem cell-related pathways such as Wnt, but this cellular inhibition cannot be phenocopied in vivo. Our study suggests the safety of NOB at regular concentration and also raises a caution to explain the inhibitory role of NOB in cancer models.

Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and In Vitro Experiments

Nobiletin Inhibits Breast Cancer Cell Migration and Invasion by Suppressing the IL-6-induced ERK-STAT and JNK-c-JUN Pathways

Nobiletin and Derivatives: Functional Compounds from Citrus Fruit Peel for Colon Cancer Chemoprevention

Effects of Nobiletin on Intestinal Stem Cell Proliferation in Vitro and in Vivo

Involvement of Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and the PI3K/AKT/mTOR Pathway in Nobiletin-Induced Apoptosis of Human Bladder Cancer Cells

Nobiletin as an inducer of programmed cell death in cancer: a review

Nobiletin inhibits cell growth through restraining aerobic glycolysis via PKA‐CREB pathway in oral squamous cell carcinoma

Inhibitory effects of nobiletin and its major metabolites on lung tumorigenesis.

Nobiletin inhibits breast cancer via p38 mitogen-activated protein kinase, nuclear transcription factor-κB, and nuclear factor erythroid 2-related factor 2 pathways in MCF-7 cells.

Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells

Nobiletin and Its Colonic Metabolites Suppress Colitis-Associated Colon Carcinogenesis by Down-Regulating Inos, Inducing Antioxidative Enzymes and Arresting Cell Cycle Progression.

Impairment of Glucose Metabolism and Suppression of Stemness in MCF-7/SC Human Breast Cancer Stem Cells by Nootkatone

The Citrus Flavonoid Nobiletin Inhibits Proliferation and Induces Apoptosis in Human Pancreatic Cancer Cells in Vitro

Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells

Nobiletin Inhibits Cell Viability Via the SRC/AKT/STAT3/YY1AP1 Pathway in Human Renal Carcinoma Cells

Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction Via Activating PPARγ and PGC1α

Inhibitory Effects Of Metabolites Of Nobiletin And 5-Hydroxy Nobiletin On Human Lung Cancer Cells

Sensitizing Effect of Nobiletin on Increased Apoptosis in Human Cancer Cells Induced by Chemotherapeutic Agents

Nobiletin inhibits de novo FA synthesis to alleviate gastric cancer progression by regulating endoplasmic reticulum stress

Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents

Nobiletin targets SREBP1/ACLY to induce autophagy-dependent cell death of gastric cancer cells through PI3K/Akt/mTOR signaling pathway